Close

We use cookies to improve your experience of our website. Privacy Policy

Skip to main content

Organ-on-a-Chip Technologies Network

Search
Menu

Dr Nathalie MAUBON

Nathalie MAUBON

CEO/CSO

HCS Pharma
+33649629950

hcs-pharma.com

Research Interests

drug discovery, High Content Screening, Cell imaging, 3D culture, Extracellular Matrix

In HCS Pharma, we work with new technologies to develop new tools for drug discovery process. First, we have internalised a new 3D groundbreaking technology named BIOMIMESYS that allow us to reproduces faithfully organ-specific Extracellular Matrix in a innovative way. Second, we use iPSC différentiated in BIOMIMESYS to have more relevant tools as human cell sources. Third, we work with academic researcher on Organ-on-Chip tools woth BIOMIMESYS to develop dynamic 3D tissue as innovative tools for secondary screening.